Not a Lexis Advance subscriber? Try it out for free.

Mealeys

Mealey's Antitrust/Unfair Competition - Panel Affirms Dismissal Of UCL, Negligence Claims Against Lexapro Manufacturers

PASADENA, Calif. - The Ninth Circuit U.S. Court of Appeals on Feb. 11 affirmed a lower federal court's dismissal of California unfair competition law (UCL) and negligence claims against manufacturers of the antidepressant drug Lexapro, finding that "the drug's packaging contained clear warning labels about a heightened risk of suicidality for adolescents" (Stephanie Patton, et al. v. Forest Laboratories Inc., et al., No. 18-56336, 9th Cir., 2020 U.S. App. LEXIS 4520).
Find full version on lexis Advance®